Tags: MDMAecstasyPTSD therapyjurisprudence2024-campaign
Profile | Contacts | Recent Articles on Subject | |
---|---|---|---|
1 | Steve Hanley Clean Technica Scientist/Author. Professor at U. Penn. University of Pennsylvania | To Regulate Or Not Too Regulate — That Is The Question - 18 days ago | |
2 | Meagan Parrish Pharma Voice Senior editor @industrydive.
Pharma world follower. Wisconsin, USA | ||
3 | Megan Lampinen Automotive World Helps understand future mobility. Global | Supply chain spotlight: risk, regulation, and compliance - about 2 months ago | |
4 | Stephen Gandel Financial Times Reinforcing priors since 1996. Manhattan, New York | ||
5 | Brooke Masters Financial Times US Financial Editor, FT. New York, USA | ||
6 | Mary E. Shacklett InformationWeek CEO, Transworld Data. | Defining an AI Governance Policy - 3 months ago Should We be Grateful for SOX and Other Regulations? - about 1 year ago | |
7 | Shelby Bradford, PhD The Scientist Assistant Editor @TheScientistLLC. Opinions my own. | What Does a Career in Science Policy Entail? - 3 months ago | |
8 | Rebecca Pifer Healthcare Dive Reporter @healthcaredive. New York City, United States | ||
9 | Joao-Pierre S. Ruth InformationWeek Senior Editor InformationWeek. Corporate goth. New Jersey | Do the EU’s Proactive Regulations Stifle Tech Innovation? - 8 months ago | |
10 | Nick Paul Taylor MedTech Dive Top 5 Mario Kart Player. | House committee tells FDA to suspend lab developed test rule - 7 months ago House committee tells FDA to suspend lab developed test rule - 7 months ago |